Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Sales | 3,411,241 | 2,942,170 | 2,473,191 | 1,907,774 | N/A |
| Cost of Goods | 3,040,011 | 2,680,940 | 2,253,097 | 1,750,091 | N/A |
| Gross Profit | 371,230 | 261,230 | 220,094 | 157,683 | N/A |
| Operating Expenses | 346,115 | 243,603 | 207,359 | 119,422 | N/A |
| Operating Income | 25,115 | 17,627 | 12,735 | 38,261 | N/A |
| Interest Expense | 10,338 | 5,164 | 8,798 | 5,477 | 4,074 |
| Other Income | 29,140 | 14,917 | 32,153 | 17,222 | 48,612 |
| Pre-tax Income | 43,917 | 27,380 | 36,090 | 50,006 | 44,538 |
| Income Tax | 43,917 | 27,380 | 36,090 | 50,006 | 44,538 |
| Net Income Continuous | 29,721 | 18,444 | 23,567 | 34,657 | 28,586 |
| Net Income | $29,721 | $0 | $23,567 | $34,657 | $28,586 |
| EPS Basic Total Ops | 0.10 | 0.07 | 0.09 | 0.15 | 0.12 |
| EPS Basic Continuous Ops | 0.10 | 0.07 | 0.09 | 0.15 | 0.12 |
| EPS Diluted Total Ops | 0.10 | 0.07 | 0.09 | 0.15 | 0.12 |
| EPS Diluted Continuous Ops | 0.10 | 0.07 | 0.09 | 0.15 | 0.12 |
| EBITDA(a) | $70,821 | $45,470 | $64,902 | $62,301 | $48,612 |